Quince Therapeutics, Inc.·4

Jun 23, 8:43 AM ET

Thye Dirk 4

4 · Quince Therapeutics, Inc. · Filed Jun 23, 2025

Insider Transaction Report

Form 4
Period: 2025-06-18
Thye Dirk
DirectorCEO and CMO
Transactions
  • Award

    Warrants

    2025-06-18$0.13/sh+150,944$18,868150,944 total
    Exercise: $1.20From: 2025-06-18Exp: 2030-06-18Common Shares (150,944 underlying)
  • Award

    Common Shares

    2025-06-18$1.20/sh+150,944$181,133994,885 total

Documents

1 file
  • 4
    form4.xmlPrimary